BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform
11. August 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Life Sciences Announces Expansion; Contract Manufacturing Capabilities, and Research and Development Laboratory
13. März 2020 09:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2020 (GLOBE NEWSWIRE) -- BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life...
BioStem Technologies, Inc. to Attend 2020 Perinatal Stem Cell Society Conference
27. Februar 2020 12:08 ET
|
BioStem Technologies, Inc.
Pompano Beach, Feb. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue-based...